Benefit of prompt initiation of single-inhaler fluticasone furoate, umeclidinium, and vilanterol (FF/UMEC/VI) in patients with COPD in England following an exacerbation: a retrospective cohort study

Afisi Ismaila, Kieran Rothnie, Robert Wood, Victoria Banks, Lucinda Camidge, Alexandrosz Czira, Chris Compton, Raj Kumar Sharma, Shannon N. Millard, Olivia Massey,

Respiratory Research · 2023 · 11 citations · 15 references

DOIFull text

Open access

Abstract

Prompt initiation of FF/UMEC/VI following a moderate/severe exacerbation was associated with fewer subsequent exacerbations, fewer hospital readmissions, and lower COPD-related medical costs compared with delayed initiation.

References

15